BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.70
0.30%
US Tech 100
20,202.80
-0.83%
S&P 500
5,998.54
-0.38%
US Dollar vs CAD
1.40309
-0.16%
Bitcoin
97,096.85
5.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Infant Bacterial Therapeutics AB (GM) (IFTBF)

  7. Infant Bacterial Therapeutics AB (GM) (IFTBF) Financials

Infant Bacterial Therapeutics AB (GM)

Infant Bacterial Therapeutics AB (GM) (IFTBF)

USOTC
8.20
0.00
( 0.00% )
Updated: 18:00:00
Delayed by 15 minutes

Infant Bacterial Therapeutics AB (GM) Financial Summary

The current IFTBF market cap is 106.75M. The company's latest EPS is SEK -9.4536 and P/E is -0.87.

Income Statement

Year End December 30 2023 20192020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Revenue 00000
Operating Income -47.2M-71.92M-44.58M-65.81M-134.62M
Net Income -46.32M-72.01M-44.99M-65.45M-123.07M

Balance Sheet

Year End December 30 2023 20192020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Assets 518.27M450.32M408.48M349.62M351.33M
Total Liabilities 7.88M10.16M13.22M17.91M46.18M
Total Equity 510.4M440.15M395.25M331.71M305.15M

Cash Flow

Year End December 30 2023 20192020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Operating -51.3M-58.39M-55.62M-85.8M-101.22M
Investing N/A N/A N/A N/A N/A
Financing N/A 1.76M91k1.88M96.52M

Stats and Ratios

Market Cap 106.75M
Price to Earnings Ratio -0.87
Price to Sales Ratio 0
Price to Cash Ratio 0.32
Price to Book Ratio 0.35
Dividend Yield -

Share Statistics

Shares Outstanding 13.02M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 9.77%
52 Week High 8.38
52 Week Low 7.47
Spread (Intraday) 0 (0%)

Company Info

Company Name Infant Bacterial Therapeutics AB (GM)
Address bryggargatan 10
stockholm SE-111 21
Website https://www.ibtherapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

USOTC
IFTBF
Infant Bacterial Therape... (GM)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68